…查看全文
$阿莱克萨制药(ALXA)$ SC TO-T/A [Amend] - Tender offer statement by Third Party Filed: 2016-06-03 AccNo: 0001341004-16-001482 Size: 107 KB 网页链接
$阿莱克萨制药(ALXA)$ SC 14D9/A [Amend] - Solicitation, recommendation statements Filed: 2016-06-03 AccNo: 0001193125-16-612799 Size: 153 KB 网页链接
$阿莱克萨制药(ALXA)$ SC TO-T - Tender offer statement by Third Party Filed: 2016-05-23 AccNo: 0001193125-16-598393 Size: 1 MB 网页链接
$阿莱克萨制药(ALXA)$ SC 14D9 - Solicitation, recommendation statements Filed: 2016-05-23 AccNo: 0001193125-16-598397 Size: 561 KB 网页链接
$阿莱克萨制药(ALXA)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-05-13 AccNo: 0001564590-16-019359 Size: 6 MB 网页链接
$阿莱克萨制药(ALXA)$ SC14D9C - Written communication relating to third party tender offer Filed: 2016-05-11 AccNo: 0001193125-16-587299 Size: 8 KB 网页链接
$阿莱克萨制药(ALXA)$ 8-K - Current report Filed: 2016-05-11 AccNo: 0001193125-16-587296 Size: 94 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$阿莱克萨制药(ALXA)$ SC14D9C - Written communication relating to third party tender offer Filed: 2016-05-10 AccNo: 0001193125-16-584794 Size: 47 KB 网页链接
$阿莱克萨制药(ALXA)$ SC TO-C - Written communication relating to an issuer or third party Filed: 2016-05-10 AccNo: 0001341004-16-001396 Size: 30 KB 网页链接
$阿莱克萨制药(ALXA)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-05-10 AccNo: 0001341004-16-001397 Size: 104 KB 网页链接